Page last updated: 2024-10-31

methylphenidate and MPTP Neurotoxicity Syndrome

methylphenidate has been researched along with MPTP Neurotoxicity Syndrome in 1 studies

Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ludolph, AG1
Schaz, U1
Storch, A1
Liebau, S1
Fegert, JM1
Boeckers, TM1

Other Studies

1 other study available for methylphenidate and MPTP Neurotoxicity Syndrome

ArticleYear
Methylphenidate exerts no neurotoxic, but neuroprotective effects in vitro.
    Journal of neural transmission (Vienna, Austria : 1996), 2006, Volume: 113, Issue:12

    Topics: Animals; Cell Line; Central Nervous System Stimulants; Dopamine; Dopamine Plasma Membrane Transport

2006